digital therapeutics

Building cognitive reserve helps delay memory and thinking decline regardless of genetic or childhood markers

by

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing time­ly brain news and a few fun brain teasers to test your per­cep­tu­al and cog­ni­tive skills.

#1. Study: Build­ing cog­ni­tive reserve helps delay mem­o­ry and think­ing decline regard­less of genet­ic or child­hood markers

“While our child­hood can influ­ence our mem­o­ry and think­ing skills lat­er in life, this research under­lines the mes­sage that it’s nev­er too late to take action to sup­port cog­ni­tive health.” — Dr Sara Imari­sio, Head of Strate­gic Ini­tia­tives at Alzheimer’s Research UK

#2. Ful­ly-auto­mat­ed analy­sis of voice recordings–from neu­ropsy­cho­log­i­cal tests–found to help dif­fer­en­ti­ate nor­mal cog­ni­tion from demen­tia and mild cog­ni­tive impairment

As the researchers point out, “The pro­posed approach offers a ful­ly auto­mat­ed iden­ti­fi­ca­tion of MCI and demen­tia based on a record­ed neu­ropsy­cho­log­i­cal test, pro­vid­ing an oppor­tu­ni­ty to devel­op a remote screen­ing tool that could be adapt­ed eas­i­ly to any language”

#3. Debunk­ing the “chem­i­cal imbal­ance” the­o­ry yet not throw­ing out the anti­de­pres­sant baby with the bathwater

“Depres­sion is usu­al­ly man­aged effec­tive­ly with anti­de­pres­sants or by talk­ing treat­ments, such as cog­ni­tive behav­iour ther­a­py, despite an incom­plete under­stand­ing of the con­di­tion and how these treat­ments work. We can­not know if treat­ments address the under­ly­ing prob­lem because we haven’t yet iden­ti­fied what that is. To imply that SSRI anti­de­pres­sants may not be worth­while is to mis­un­der­stand an evi­dence base that says the very opposite.”

#4. Q&A with researcher Robb Rut­ledge on men­tal health, expec­ta­tions, deci­sion-mak­ing and hol­i­day planning

“Recent events have a big­ger impact on hap­pi­ness than ear­li­er events, so it can be a good strat­e­gy to save a cou­ple things that have a chance of a big pos­i­tive sur­prise for the last few days of your trip. It could be a nov­el expe­ri­ence that a lot of peo­ple like but you’re not sure what to expect … It prob­a­bly isn’t anoth­er muse­um. Just make sure it’s not some­thing that could get rained out”

#5. How much should you trust Bet­ter­Help, Talk­space, Cere­bral and oth­er men­tal health start-ups tout­ed by celebrities?

“Many U.S. adults aren’t able to find help because of a short­age of ther­a­pists. Near­ly 40% are strug­gling with men­tal health or sub­stance abuse issues, accord­ing to the Cen­ters for Dis­ease Con­trol and Prevention.
So mil­lions of peo­ple are turn­ing to online companies…”

#6. Dig­i­tal men­tal health inter­ven­tion by the World Health Orga­ni­za­tion (WHO) found to low­er anx­i­ety and depres­sion, with improve­ments main­tained at 3?month follow-up

As acknowl­edged “The main lim­i­ta­tion of the cur­rent tri­al is the high dropout rate”, but con­text is key: “Most dis­placed peo­ple with men­tal dis­or­ders in low- and mid­dle-income coun­tries do not receive effec­tive care, and their access to care has dete­ri­o­rat­ed dur­ing the Coro­n­avirus Dis­ease 2019 (COVID-19) pan­dem­ic”. — Inno­va­tion does­n’t need to be per­fect, just better/ cheaper/ more acces­si­ble than alternatives.

#7. Dig­i­tal ther­a­peu­tics pio­neer Akili Inter­ac­tive Labs goes pub­lic, rais­ing $150M+; trades down 49% first day

Quite dif­fi­cult mar­ket envi­ron­ment for an impor­tant evi­dence-based inno­va­tion — good news is they raised enough funds to test approach in the real world over the next 12–24 months. Let’s see!

#8. Arti­fi­cial Intel­li­gence (AI) meets Cog­ni­tive Behav­ioral Ther­a­py (CBT): Wysa rais­es $20M to scale up men­tal health chatbot

“Typ­i­cal­ly, access to a men­tal health ser­vice is gat­ed. It is restrict­ed by some kind of diag­no­sis — say­ing only if you are severe enough you will be able to get to speak to a ther­a­pist because obvi­ous­ly ther­a­py is expen­sive and somebody’s got to pay for it” … the app offers “ear­ly engage­ment and a safe space where peo­ple can come in and anony­mous­ly just talk about what’s both­er­ing them.”

Final­ly, here are three quick brain teas­er games to test your per­cep­tu­al and cog­ni­tive skills. Wish­ing you and yours a healthy and stim­u­lat­ing month of September!

Digital therapeutics pioneer Akili Interactive Labs goes public, raising $150M+; trades down 49% first day

by

Akili Inter­ac­tive is the lat­est com­pa­ny to go pub­lic via SPAC deal (Boston Busi­ness Journal):

Boston’s Akili Inter­ac­tive Labs Inc. is the lat­est Mass­a­chu­setts-based com­pa­ny to go pub­lic after com­plet­ing a reverse merg­er — in a year of mar­ket tur­moil that saw few local firms pass­ing the thresh­old between pri­vate and pub­lic status.

Shares of Akili start­ed trad­ing on Mon­day on the Nas­daq Cap­i­tal Mar­ket under the new tick­er sym­bol “AKLI” after the com­pa­ny com­plet­ed its pre­vi­ous­ly announced reverse merg­er with Social Cap­i­tal Suvret­ta Hold­ings Corp. I (Nas­daq: DNAA), a spe­cial pur­pose acqui­si­tion com­pa­ny, or SPAC. [Read more…] about Dig­i­tal ther­a­peu­tics pio­neer Akili Inter­ac­tive Labs goes pub­lic, rais­ing $150M+; trades down 49% first day

Artificial Intelligence (AI) meets Cognitive Behavioral Therapy (CBT): Wysa raises $20M to scale up mental health chatbot

by

Wysa rais­es $20 mil­lion to expand its ther­a­pist chat­bot into a wider set of men­tal health ser­vices (TechCrunch):

Wysa, a pop­u­lar men­tal health app orig­i­nal­ly found­ed in India around an AI chat­bot that helps users talk through their feel­ings, has raised $20 mil­lion in a Series B fund­ing round to expand its busi­ness on the heels of hit­ting 4.5 mil­lion users in 65 countries.

The all-equi­ty round is led by India’s dig­i­tal health-focused ven­ture cap­i­tal fund HealthQuad, with par­tic­i­pa­tion also from British Inter­na­tion­al Invest­ment (BII), the U.K.’s devel­op­ment finance insti­tu­tion. The plan will be to use the mon­ey to dou­ble down on its home mar­ket as well as the U.S. and U.K, where it already has respec­tive­ly had approvals from the FDA and the Nation­al Health Ser­vice (NHS) and is used by the lat­ter as part of its online men­tal health ser­vices. [Read more…] about Arti­fi­cial Intel­li­gence (AI) meets Cog­ni­tive Behav­ioral Ther­a­py (CBT): Wysa rais­es $20M to scale up men­tal health chatbot

On mental fitness beliefs, lifestyles and new tools like apps, digital therapeutics, virtual reality, “brain age gaps” and more

by

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing time­ly brain & men­tal health news and a fun cou­ple of math brain teasers.

#1. Study on the “ABCs of Men­tal Health” finds that sim­ply believ­ing you can improve men­tal well­be­ing helps actu­al­ly improve it

Beliefs mat­ter.

#2. “Dig­i­tal ther­a­peu­tics” vs. “Men­tal health apps”: A grow­ing debate on stan­dards, reg­u­la­tion and efficacy

Def­i­n­i­tions matter.

#3. How ’sleep­ing on it’ can help the pre­frontal cor­tex reg­u­late emo­tion­al respons­es, mak­ing us feel bet­ter in the morning

Sleep mat­ters.

#4. NICE in the UK issues rec­om­men­da­tion for Sleepio app, the dig­i­tal cog­ni­tive behav­iour­al ther­a­py for insom­nia by Big Health

Inno­va­tion mat­ters: “At a price of £45 per per­son, Sleepio is cost sav­ing com­pared with usu­al treat­ment in pri­ma­ry care. This is based on an analy­sis of pri­ma­ry care resource use data before and after Sleepio was intro­duced in 9 GP prac­tices. Health­care costs were low­er at 1 year, most­ly because of few­er GP appoint­ments and sleep­ing pills prescribed.”

#5. New book pro­vides prac­ti­cal guid­ance for women (and men) to rebal­ance our lifestyles and build Cog­ni­tive Reserve

Lifestyle mat­ters: “The more com­plex our lives are, the more we need sim­ple things that can ground us and help us to be more resilient – to rebal­ance and rebal­ance and rebal­ance again. Build­ing the men­tal mus­cles to find bal­ance when one gets off bal­ance is a crit­i­cal skill thrive and to build cog­ni­tive reserve in our fast-chang­ing times. As our month­ly gath­er­ings showed us over the years, prac­tic­ing rebal­ance in good com­pa­ny not only rein­forces neur­al path­ways and capa­bil­i­ties but also strength­ens the bonds of trust and con­fi­dence that are invalu­able to build a healthy envi­ron­ment to thrive in.”

#6. Study: Auto­mat­ed VR psy­chother­a­py can help reduce anx­i­ety and dis­tress, espe­cial­ly among those with psy­chosis and severe agoraphobia

One of the ben­e­fits of VR is that patients know they are in a sim­u­la­tion, which enables “psy­cho­log­i­cal dis­tance from prob­lem­at­ic reac­tions,” the study authors wrote. “The process of find­ing the best uses and imple­men­ta­tion meth­ods of this immer­sive tech­nol­o­gy at scale in men­tal health is only beginning.”

#7. Fund­ing for dig­i­tal health start-ups, espe­cial­ly in men­tal health, fall sub­stan­tial­ly in Q1’22

“While all tech sec­tors received small­er fund­ing totals than the pre­vi­ous quar­ter, dig­i­tal health plunged much fur­ther than oth­ers did … investor inter­est in men­tal health tech wavered as the mar­ket and pub­lic com­pa­nies like Talk­space and Cere­bral come under scrutiny.”

#8. Deep learn­ing mod­el built on neu­roimag­ing data iden­ti­fies “Brain Age Gaps” as mark­ers of Alzheimer’s dis­ease (AD)

“The main find­ing of our study is that we could indeed find evi­dence that high brain age gap is behav­ing as an accel­er­at­ed brain aging bio­mark­er.” — Dr. David Jones, neu­rol­o­gist at Mayo Clinic

Final­ly, a cou­ple fun brain teasers to help you flex your math/ cog­ni­tive men­tal muscles:

#9. Will you fin­ish your the­sis on time?

#10. Math brain teas­er requir­ing no math — just per­cep­tion and cognition

 

Wish­ing you and yours a healthy and stim­u­lat­ing June!

“Digital therapeutics” vs. “Mental health apps”: A growing debate on standards, regulation and efficacy

by

The effi­ca­cy of Men­tal Health Apps (phar­mafo­rum):

In Jan­u­ary, PLOS Dig­i­tal Health pub­lished a study which claimed that there’s “sparse” data to sup­port the effi­ca­cy of most men­tal health apps.

In their meta-analy­sis of pub­lished stud­ies, the authors found uni­ver­sal defi­cien­cies and con­clud­ed that there’s no con­vinc­ing evi­dence that app-based inter­ven­tions deliv­er mean­ing­ful out­comes. With­out dig­ging fur­ther, one might think the cur­rent case for dig­i­tal ther­a­peu­tics is weak.

I reviewed all 14 meta-analy­ses includ­ed in the study and found the analy­sis to be accu­rate, but incom­plete. [Read more…] about “Dig­i­tal ther­a­peu­tics” vs. “Men­tal health apps”: A grow­ing debate on stan­dards, reg­u­la­tion and efficacy

News on how the brain changes over time, how to clear foggy brains, how to multitask (or not), and more

by

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing time­ly brain & men­tal health news and a fun brain teas­er to test the lim­its of multi-tasking.

#1. Col­lab­o­ra­tive neu­roimag­ing ini­tia­tive Brain­Chart helps chart how brains change across the lifes­pan. Among the many fas­ci­nat­ing findings:

“The vol­ume of grey mat­ter (brain cells) increas­es rapid­ly from mid-ges­ta­tion onwards, peak­ing just before we are six years old. It then begins to decrease slowly.”
“The vol­ume of white mat­ter (brain con­nec­tions) also increased rapid­ly from mid-ges­ta­tion through ear­ly child­hood and peaks just before we are 29 years old.”
“The decline in white mat­ter vol­ume begins to accel­er­ate after 50 years.”

#2. Five ways to clear fog­gy brains and improve cog­ni­tive well-being

“Become more inten­tion­al about con­sum­ing news … news­pa­pers, TV news pro­grams, and many social media sites make their mon­ey by grab­bing your attention—and noth­ing grabs atten­tion bet­ter than neg­a­tive news. But repeat­ed expo­sure to crises wreaks hav­oc with our well-being and can lead to bad deci­sion making.”

#3. As announced in our pre­vi­ous e‑newsletter, the Cen­ter for Brain­Health at UT-Dal­las host­ed a talk titled Nav­i­gat­ing the Brain Health Mar­ket with Álvaro Fer­nán­dez Ibáñez on April 21st. We had over a thou­sand par­tic­i­pants, hun­dreds of com­ments and a superb Q&A at the end — you can enjoy the full ses­sion record­ing HERE, over at YouTube.

#4. Map­ping ‘psy­che­del­ic trips’ in the brain to bet­ter direct their ther­a­peu­tic effects

“Our study shows that it’s pos­si­ble to map the diverse and wild­ly sub­jec­tive psy­che­del­ic expe­ri­ences to spe­cif­ic regions in the brain. These insights may lead to new ways to com­bine exist­ing or yet to be dis­cov­ered com­pounds to pro­duce desired treat­ment effects for a range of psy­chi­atric conditions.”

#5. Altoi­da rais­es fur­ther $14 mil­lion to “democ­ra­tize dig­i­tal cog­ni­tive assess­ment at scale” via aug­ment­ed real­i­ty (AR) and AI

“Through an app down­loaded to a patient’s own smart­phone or tablet, Altoida’s tech first offers up a 10-minute test. A vari­ety of Aug­ment­ed Real­i­ty (AR)-powered exer­cis­es mea­sure 11 areas of the brain that have been linked to Alzheimer’s. The video-game-like activ­i­ties ask users to hide and relo­cate vir­tu­al objects around the room, sim­u­late a fire evac­u­a­tion and search for vir­tu­al items while a sound con­tin­u­ous­ly plays .. The result­ing report high­lights symp­toms of cog­ni­tive decline—such as hand and gait errors, eye track­ing, pupil dila­tion and more—and pro­vides a score of the like­li­hood that they’ll devel­op Alzheimer’s with­in the next year.”

#6. Geisinger and Eisai to test real-world valid­i­ty of AI-pow­ered Pas­sive Dig­i­tal Mark­er (PDM) in detect­ing ear­ly cog­ni­tive impair­ment and dementia

“As an imple­men­ta­tion sci­en­tist, it is always excit­ing to have oth­er sci­en­tists eval­u­ate the repro­ducibil­i­ty of the per­for­mance of our pas­sive dig­i­tal mark­er in very dif­fer­ent pop­u­la­tions,” said Malaz Bous­tani, M.D., Richard M. Fair­banks Pro­fes­sor of Aging Research at Indi­ana Uni­ver­si­ty. “Repro­ducibil­i­ty is the cor­ner­stone of sci­en­tif­ic progress.”

#7. Debate: Will dig­i­tal ther­a­peu­tics gain the required lev­els of aware­ness, adop­tion, reim­burse­ment and ful­fill­ment to become sustainable?

“There’s still a lot of foun­da­tion­al work that needs to be done,” said Maya Desai, direc­tor of life sci­ences for Guide­house. “There’s a lot of behav­ioral change that needs to hap­pen across the stake­hold­ers and their mind­sets to think about dig­i­tal ther­a­peu­tics as a cat­e­go­ry of its own.”

#8. And, yes, here’s the quick brain teas­er to test the lim­its of multitasking

 

Wish­ing you and yours a healthy and stim­u­lat­ing May … Sum­mer is Coming.

 

The Sharp­Brains Team